Detalhe da pesquisa
1.
Pemigatinib for metastatic or surgically unresectable urothelial carcinoma with FGF/FGFR genomic alterations: final results from FIGHT-201.
Ann Oncol
; 35(2): 200-210, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37956738
2.
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.
Ann Oncol
; 32(6): 787-800, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33746047
3.
Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial.
ESMO Open
; 6(3): 100101, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33901870
4.
Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders.
J Immunother Cancer
; 6(1): 159, 2018 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30591082
5.
Erratum to 'Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial': [ESMO Open Volume 6, Issue 3, June 2021, 100101].
ESMO Open
; 6(4): 100177, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34474809
6.
Initial Report of a Randomized Trial Comparing Conventional- vs Conventional plus Fluciclovine (18F) PET/CT Imaging-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys
; 108(5): 1397, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33427655